Envista (NVST) Expected to Announce Quarterly Earnings on Thursday

Envista (NYSE:NVST) is expected to be announcing its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect the company to announce earnings of $0.32 per share and revenue of $680.2550 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 5, 2026 at 5:00 PM ET.

Envista Stock Down 0.9%

Shares of NVST opened at $23.25 on Tuesday. Envista has a fifty-two week low of $14.22 and a fifty-two week high of $25.41. The company’s fifty day moving average is $22.47 and its two-hundred day moving average is $21.10. The firm has a market cap of $3.82 billion, a PE ratio of 258.36, a price-to-earnings-growth ratio of 1.05 and a beta of 0.99. The company has a quick ratio of 2.02, a current ratio of 2.37 and a debt-to-equity ratio of 0.47.

Institutional Trading of Envista

A number of hedge funds have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd boosted its stake in shares of Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Envista by 378.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after buying an additional 1,909 shares in the last quarter. Quarry LP purchased a new position in Envista in the 3rd quarter valued at about $66,000. Finally, Virtus Advisers LLC acquired a new stake in shares of Envista during the third quarter valued at about $205,000.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research report on Monday, January 26th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. JPMorgan Chase & Co. increased their target price on shares of Envista from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Tuesday, December 16th. Mizuho set a $24.00 price target on shares of Envista and gave the company a “neutral” rating in a report on Tuesday, January 20th. Finally, Evercore ISI reiterated an “outperform” rating on shares of Envista in a research note on Friday, October 31st. Five investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Envista has an average rating of “Hold” and an average price target of $22.33.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.